Literature DB >> 15073583

Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.

Goutam Karan1, Zhenglin Yang, Kang Zhang.   

Abstract

PURPOSE: ELOVL4 is a member of the fatty acid elongase (ELO) family of genes. Mutations of this gene are responsible for autosomal dominant Stargardt-like macular degeneration. However, the specific role of ELOVL4 in photoreceptor cells and the mechanism by which mutations in ELOVL4 causes macular degeneration are not known. In this study we examined the subcellular localization of wild type (wt) and mutant (mt) ELOVL4 EGFP fusion protein and the potential functional consequence of mtELOVL4 expression on cell viability.
METHODS: Wt and mt ELOVL4 were expressed as EGFP fusion proteins in NIH 3T3 and HEK293 cells. Subcellular localizations of the fusion proteins were determined with a series of organelle-specific markers for endoplasmic reticulum (pDsRed2-ER), mitochondria (pDsRed2-Mito), peroxisomes (pDsRed2-Peroxi), and Golgi (BODIPY TR). Transfected cells were viewed using confocal and episcopic-fluorescence microscopy. Western blot analysis was performed to assess protein expression using an anti-GFP antibody. TUNEL staining was used to quantify apoptotic cell death.
RESULTS: In cell transfection studies, wtELOVL4/EGFP fusion protein localized preferentially to the endoplasmic reticulum (ER) and was not found to be discernibly present in mitochondria, peroxisomes, or Golgi. In contrast, the truncated mutant fusion protein (which has no ER retention signal) appeared to be mislocalized to other compartments within transfected cells. Transfected cells expressing mtELOVL4/EGFP fusion protein exhibited induction of apoptotic cell death.
CONCLUSIONS: Unlike wtELOVL4/EGFP fusion protein, the mtELOVL4/EGFP fusion protein did not localize to the ER but rather appeared to be sequestered elsewhere in an aggregated pattern in the cytoplasm. The apoptosis induced by the mutant ELOVL4 fusion protein may be the mechanism whereby photoreceptor cells degenerate in Stargardt-like macular degeneration. Our study has provided an important in vitro model system for further assessment of ELOVL4 biochemical functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073583

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  21 in total

Review 1.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

Review 2.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

3.  Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.

Authors:  Dorit Raz-Prag; Radha Ayyagari; Robert N Fariss; Md Nawajes A Mandal; Vidyullatha Vasireddy; Sharon Majchrzak; Andrea L Webber; Ronald A Bush; Norman Salem; Konstantin Petrukhin; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

Review 4.  Protein misfolding and retinal degeneration.

Authors:  Radouil Tzekov; Linda Stein; Shalesh Kaushal
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

5.  Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy.

Authors:  Gabriele Di Sante; Mathew C Casimiro; Timothy G Pestell; Richard G Pestell
Journal:  J Vis Exp       Date:  2016-05-04       Impact factor: 1.355

6.  An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.

Authors:  Kang Zhang; Yuko Harada; Xinran Wei; Dhananjay Shukla; Anand Rajendran; Khaled Tawansy; Matthew Bedell; Sharon Lim; Peter X Shaw; Xi He; Zhenglin Yang
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

7.  A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology.

Authors:  Anne McMahon; Hua Lu; Igor A Butovich
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

8.  A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines.

Authors:  Anne McMahon; Shelley N Jackson; Amina S Woods; Wojciech Kedzierski
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

9.  Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.

Authors:  Peter Barabas; Aihua Liu; Wei Xing; Ching-Kang Chen; Zongzhong Tong; Carl B Watt; Bryan W Jones; Paul S Bernstein; David Križaj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 10.  Genetics and molecular pathology of Stargardt-like macular degeneration.

Authors:  Vidyullatha Vasireddy; Paul Wong; Radha Ayyagari
Journal:  Prog Retin Eye Res       Date:  2010-01-21       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.